Long term development of diastolic dysfunction and heart failure with preserved left ventricular ejection fraction in heart transplant recipients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 03 2022
Historique:
received: 10 11 2021
accepted: 28 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 19 4 2022
Statut: epublish

Résumé

Heart transplant recipients (HTX) have several risk factors for heart failure which can trigger pro-inflammatory and fibrosis factors and set into motion pathophysiologic changes leading to diastolic dysfunction and HFpEF. The objective of the study was to determine if HTX recipients with dyspnea have diastolic dysfunction and HFpEF. Twenty-five HTX were included. LV systolic and diastolic functions were evaluated using conductance catheters to obtain pressure volume loops. LV function was assessed at rest and during moderate intensity exercise of the upper extremities. A significant increase occurred in LV minimal pressure (3.7 ± 3.3 to 6.5 ± 3.5 mmHg) and end diastolic pressure or EDP (11.5 ± 4 to 18 ± 3.8 mmHg, both P < 0.01) with exercise. With exercise, the time constant of LV relaxation shortened in 2, was unchanged in 3, and increased in the remaining patients (group results: rest 40 ± 11.6 vs 46 ± 9 ms, P < 0.01). LV chamber stiffness constant was abnormally increased in all but 2 patients. Indices of LV systolic properties were normal at rest but failed to augment with exercise. In 15 who agreed to blood draw, inflammation and fibrosis markers were obtained. A significant association was observed between LV EDP and Pro-Col III N-terminal (r = 0.58, P = 0.024) and IL-1-soluble receptor (r = 0.59, P = 0.02) levels. HTX have diastolic dysfunction and can develop HFpEF several years after cardiac transplantation. The abnormally increased LV chamber stiffness and the prolongation or lack of shortening of the time constant of LV relaxation with exercise are the underlying reasons behind the observed changes in LV diastolic pressures with exercise.

Identifiants

pubmed: 35264640
doi: 10.1038/s41598-022-07888-9
pii: 10.1038/s41598-022-07888-9
pmc: PMC8907212
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3834

Informations de copyright

© 2022. The Author(s).

Références

Arq Bras Cardiol. 2011 Jul;97(1):65-75
pubmed: 21584478
Circulation. 1988 May;77(5):1116-24
pubmed: 3359589
Circ Heart Fail. 2021 May;14(5):e007555
pubmed: 33951935
Circulation. 1989 Jan;79(1):66-75
pubmed: 2642757
Circulation. 1992 Oct;86(4):1175-85
pubmed: 1382887
Circulation. 2000 Oct 24;102(17):2100-4
pubmed: 11044427
Arch Cardiovasc Dis. 2016 Apr;109(4):254-9
pubmed: 26993361
Circulation. 2008 Apr 22;117(16):2051-60
pubmed: 18413502
Circ Heart Fail. 2013 Sep 1;6(5):953-63
pubmed: 23797369
J Appl Physiol (1985). 2006 Jun;100(6):1895-901
pubmed: 16497838
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
J Clin Invest. 1976 Sep;58(3):751-60
pubmed: 956400
Circulation. 2013 Sep 24;128(13):1470-9
pubmed: 24060943
JACC Heart Fail. 2017 Dec;5(12):869-878
pubmed: 29191294
J Heart Lung Transplant. 2009 Aug;28(8):759-68
pubmed: 19632570
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H403-12
pubmed: 16428349
Eur J Heart Fail. 2015 Feb;17(2):151-8
pubmed: 25488133
Bull Eur Physiopathol Respir. 1979 Sep-Oct;15(5):935-49
pubmed: 508986
Eur Heart J. 2007 Oct;28(20):2539-50
pubmed: 17428822
Circulation. 2007 Aug 7;116(6):637-47
pubmed: 17646587
Eur Heart J. 2018 May 21;39(20):1799-1806
pubmed: 28087606
Circulation. 1972 Jun;45(6):1183-94
pubmed: 4555848
Circulation. 2007 Apr 17;115(15):1982-90
pubmed: 17404159
Circulation. 2018 Aug 28;138(9):861-870
pubmed: 29792299

Auteurs

Pimprapa Vejpongsa (P)

Houston Methodist Hospital, 6550 Fannin, SM-1832, Houston, TX, 77025, USA.

Guillermo Torre-Amione (G)

Houston Methodist Hospital, 6550 Fannin, SM-1832, Houston, TX, 77025, USA.

Hernan G Marcos-Abdala (HG)

Houston Methodist Hospital, 6550 Fannin, SM-1832, Houston, TX, 77025, USA.

Salil Kumar (S)

Houston Methodist Hospital, 6550 Fannin, SM-1832, Houston, TX, 77025, USA.

Keith Youker (K)

Houston Methodist Hospital, 6550 Fannin, SM-1832, Houston, TX, 77025, USA.

Arvind Bhimaraj (A)

Houston Methodist Hospital, 6550 Fannin, SM-1832, Houston, TX, 77025, USA. abhimaraj@houstonmethodist.org.

Sherif F Nagueh (SF)

Houston Methodist Hospital, 6550 Fannin, SM-1832, Houston, TX, 77025, USA. snagueh@houstonmethodist.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH